Palvella Therapeutics PVLA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$15.77M-92.6% | -$12.71M-110% | -$11.35M-293% | -$9.47M-164% | -$8.19M-223% | ||
| $3.38M+209% | $2.08M+678% | $1.79M+799% | $1.43M+560% | $1.09M+649% | ||
| -$10.86M-60.5% | -$4.93M+8.7% | -$7.88M-187% | -$5.43M-239% | -$6.77M-514% | ||
| -$55.44M— | —— | —— | —— | $0-100% | ||
| $214.73M+17,964% | -$49K-100% | —— | —— | -$1.2M— | ||
| $148.41M+1,961% | -$5.59M-108% | -$6.87M— | -$5.19M-163% | -$7.98M-624% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Palvella Therapeutics generate?
- Palvella Therapeutics (PVLA) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Palvella Therapeutics's free cash flow?
- Palvella Therapeutics's free cash flow was -$15.2M over the trailing twelve months, up 67.1% year over year.
- Where does Palvella Therapeutics's cash flow data come from?
- Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
